Also from this source

You just read:

JHL Biotech's Clinical Trial Application Accepted by China for Bevacizumab Biosimilar to Treat Colorectal, Lung, and Ovarian Cancers

News provided by

JHL Biotech, Inc.

Apr 16, 2018, 06:22 ET